Product/Composition:- | Hydroxyurea |
---|---|
Strength:- | Capsules: 200 mg, 300 mg, 400 mg, 500 mg; Tablets: 100 mg, 500 mg, 1,000 mg |
Form:- | Capsules and Tablets |
Reference Brands:- | Hydrea, Droxia , Siklos |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Hydroxyurea is an oral cytoreductive drug used for sickle cell disease, CML, and polycythemia vera. Available in 100–500 mg strengths under brands like Hydrea, Droxia, and Siklos. Ideal for pharma B2B sourcing and global bulk supply.
Hydroxyurea is a widely used oral chemotherapeutic and hematologic drug indicated for sickle cell disease, chronic myeloid leukemia (CML), polycythemia vera, and essential thrombocythemia. It works by inhibiting DNA synthesis and increasing fetal hemoglobin (HbF) in sickle cell patients. Marketed under brands like Hydrea, Droxia, and Siklos, it is available in 100 mg to 500 mg capsules and tablets. Manufactured under GMP standards, Hydroxyurea is ideal for pharmaceutical distributors, hospitals, and global B2B buyers. We offer competitive pricing, regulatory documentation, and reliable bulk supply. Contact us today for high-quality Hydroxyurea sourcing and international export support.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications